chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After receiving the two vaccines Influenza and Meningococcal B and the TB PPD test the patient fainted on the examination table. She lost consciousness momentarily for a few seconds. Patient's HR was 49 oxygen 97-98%. When patient awake she felt light headed, cool, clammy, and pale. Initial vital signs were HR 49, BP 99/57, oxygen 97, second vital signs BP 116/76, HR 72, oxygen 98%, third vital signs BP 116/73, HR 76, oxygen 97%. Patient was observed for 30 minutes. Before leaving the clinic she denied dizziness, able to ambulate without difficulty, skin warm and pink. Patient never developed a rash, shortness of breath, hives, or difficulty breathing. Patient was called 2 hours after going home. Denies fainting episode again but did report a mild headache and feeling little tired. Patient denied other new symptoms. Patient instructed to go to ED if new symptoms develop. Patient reports a history of fainting after giving blood in the past.
immediately after the vaccine patient described right side of face and neck itching. Now one week later; patient has a rash right side of face and neck also has a small rash left medial upper arm anteriorly
Bad rash on arm, itching and burning. Swollen lymph nodes even today (12/10/21) in throat and at elbows. Rash with itchy hives appeared on chest, spreading.
Erythema, warmth, swelling at injection site with erythema extending into the underarm. Recommended cool compress/ice pack, Tylenol, antihistamine, fluids and rest. Discussed ED precautions over the weekend, or on call provider.
Breakthrough  case admission after 2 vaccines Pfizer 7/27/21 Lot# FA7485;  Pfizer 8/18/21 Lot# FA7484
Patient started feeling pain in arm 3 weeks after vaccination in 2021. In April 2023 patient is getting pains in the arm again. in July 2023 patient has tingling in her arm.
Forehead broke out; On right cheek two small lumps; Top of head itching like crazy; Top of chest down to my boobs broke out; My back is starting to itch, like creepy ants crawling all over; Pin point red dots on stomach and legs but not itching; One arm is a little broke out; Real tired; This spontaneous case was reported by a consumer and describes the occurrence of ACNE (Forehead broke out), SWELLING FACE (On right cheek two small lumps), PRURITUS (Top of head itching like crazy), ACNE (Top of chest down to my boobs broke out) and PRURITUS (My back is starting to itch, like creepy ants crawling all over) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Panic attacks and Thyroid disorder NOS (Thyroid). Concomitant products included LEVOTHYROXINE and CLONAZEPAM for an unknown indication.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced ACNE (Forehead broke out), SWELLING FACE (On right cheek two small lumps), PRURITUS (Top of head itching like crazy), ACNE (Top of chest down to my boobs broke out), PRURITUS (My back is starting to itch, like creepy ants crawling all over), RASH ERYTHEMATOUS (Pin point red dots on stomach and legs but not itching), RASH (One arm is a little broke out) and FATIGUE (Real tired). At the time of the report, ACNE (Forehead broke out), SWELLING FACE (On right cheek two small lumps), PRURITUS (Top of head itching like crazy), ACNE (Top of chest down to my boobs broke out), PRURITUS (My back is starting to itch, like creepy ants crawling all over), RASH ERYTHEMATOUS (Pin point red dots on stomach and legs but not itching), RASH (One arm is a little broke out) and FATIGUE (Real tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were unknown.
Fainted/fell unconscious in chair immediately after injection.   Out for 20 seconds or so. Reportedly stiff as a board and twitchy.  No significant history of fainting.
Patient  called to report that he has difficulty breathing and suspects it may be related to the Moderna covid vaccine he received 4 days ago. He has been advised to call 911 for help and this will be reported to VIS
pain/swelling to left axillary area, than pain felt across upper chest above left breast, no lymphadenopathy Narrative:
Day after vaccine site became red, inflamed, warm to touch, itchy. Two days later redness spread. By third day entire upper arm was infected. After trying to reach clinic for 2 days , where, I received the vaccine, I opted to go to Immediate care. The Dr diagnosed me with an adverse reaction, possibly cellulitis and treated me with an antibiotic , steroid and topical cream.
Pt reports she has started to see an increase in joint pain in her hands, these symptoms did start before vaccination and she has family hx of RA. She has been referred to Rheumatologist but has not seen yet. She stated she had her first flare up in her hands a couple days after her Pfzer Covid vaccine on 04/23/2021 and also after the second on 05/26/2021. She is still having pain in her hands, seems to get worse every week, sometimes cannot straighten her middle finger, seems to happen relatively frequently
Vaccine was diluted incorrectly, patient received higher dose than the intended diluted 0.3 ML
dazed state-fever-took to hosp given Ativan to stop the sz;pt was put on phenobarbital for control of sz & had 2 sz since 5FEB94 & 5NOV96;
pt developed fever to 103 night of 11/11/2021 and wheezing with hoarseness and nasal congestion
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Mar2021 at 14:30 as dose 1, single (Lot number: EN6206), in left arm, on 19Mar2021 at 10:30 as dose 2, single (Lot number: EN6207), in left arm, on 26Oct2021 at 16:00 as dose 3 (booster), single (Lot number: FF8841), in left arm and on 18Apr2022 at 15:15 as dose 4 (booster), single (Lot number: FJ4991) at the age of 67 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 05Sep2022 at 10:00, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (05Sep2022) Positive, notes: Positive COVID infection 05Sep2022 and Rebound COVID infection 19Sep2022; (19Sep2022) Positive, notes: Positive COVID infection 05Sep2022 and Rebound COVID infection 19Sep2022. Therapeutic measures were taken as a result of vaccination failure, covid-19.
pt felt achy evening of 5OCT98 p/vax;6OCT98 rt arm swelled, hands swelled, & throat began to close;went to ER was sent home w/tx;I was dying pt stated;
No adverse events noted. Given HPC instead of MENACTRA as ordered by MD. Last HPV #3 given 7-29-14.
exp large red spot @ site of inj was warm & swollen x many wks, nausea, dull ache, severe muscle pain, tremors, spasms & twitching, progressing to convuls;diff breathing;burning sensation, fever;cont stiffness,weakness, visual disturbances
Information has been received from a physician concerning a female who on 21-MAR-2007 was vaccinated with the first oral dose Rotateq. On 16-MAY-2007, the patient was vaccinated with the second oral dose of Rotateq. On 19-JUL-2007, the patient was vaccinated with the third oral dose of Rotateq. All three doses were administered at a health clinic. After the patient received the third dose the patient went into the physician's office because he had a fever that was persistent for five days. The patient was then admitted to the hospital on 07-SEP-2007. On 08-SEP-2007, the patient was transferred to another hospital. The patient received two echocardiograms and also was treated for Kawasaki disease (the physician was unsure if the disease was confirmed). The patient was treated with antibiotics, aspirin, and IV immune globulin. The patient was discharged from the hospital but the date of discharge was not known. The outcome was reported as unknown. There was no product quality complaint. Additional information has been requested.  12/10/2007 MR received for DOS 9/8-11/2007 with Final DX: Incomplete Kawasaki, Enterovirus.  Infant developed fever of 102 on 9/2/07 with no other sx initially.  Fever continued and infant was treated with abx for pharyngitis and then an otitis media.  However, fever continued despite abx and anti-pyretics.  Child then began to experience diarrhea with one episode of blood in stool on the day prior to admission as well as non-productive cough.  No reports of rashes or swelling at this time, although infant was noted to have red eyes thought to be 2' to crying.  Admitted to local hospital where conjuctivitis, (non-purulent), and questionable dry, cracked lips and palmar erythema were noted, however this was not noted upon admission to transfer facility. Txd with IVIG and ASA for atypical Kawasaki's.  Pt tolerated IVIG well and improved symptomatically and clinically with reduction in fever by D/C
Pain and swelling in left armpit and raised red rash around and below injection site. Starting day 7
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Medical history, concurrent conditions, and concomitant medications were not provided. On or about 12-JUL-2015, the patient was inoculated with ZOSTAVAX vaccine (Dose, route of administration, site of administration, Lot number and expiration date were not provided) at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. During 2016, the patient was treated (by an unspecified healthcare professional) at a hospital (not further specified if admitted) for a blistering vesicular outbreak, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, she has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The reporter considered the events to be related to ZOSTAVAX. The outcome of the events was unknown. Additional information has been requested.
Patient ate her cereal late the next morning. She has been eating the same cereal for years. She said she had an anaphylactic reaction, which was resolved by taking Benadryl 50MG. Her children are all allergic to tree nuts. She ate the same cereal on Monday and said she had another anaphylactic reaction. She now believes she is allergic to tree nuts.
Patient received her second dose of vaccine on 4/6/23 and reported to the pharmacy on 4/12/23 that soreness started on 4/7/23 and felt the pain had increase in severity since 4/7/23.  Patient reported injection site felt warm but was negative for redness or swelling.  Up until this point the patient had not tried any treatments for pain such as acetaminophen, NSAID's or topical treatments such as ice.
Patient developed a temperature of 102.9 orally at 5:30 pm.  MD notified, APAP 650mg po administered. Temp at 9:00 pm 99.4.  Patient also had poor appetite
Pt called 11/4 to state she had 2 spots on arm that received pneumovax 2 days ago.  1 is good sized (3 in a row) and 1 smaller.  RPh advised watch and wait as we are just 2 days out.  Shared that pt can use cold compress as well as otc pain meds.  If area increases in size, streaks, etc.  please call back so we can further investigate.
red swollen injection site; red swollen injection site; reduced (not total numbness) sense of feeling in her entire left arm and hands; she felt a burning sensation; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (she felt a burning sensation), VACCINATION SITE ERYTHEMA (red swollen injection site), VACCINATION SITE SWELLING (red swollen injection site) and SENSORY LOSS (reduced (not total numbness) sense of feeling in her entire left arm and hands) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 prophylaxis: SPIKEVAX and MODERNA COVID-19 VACCINE. Past adverse reactions to the above products included No adverse event with MODERNA COVID-19 VACCINE and SPIKEVAX.    On 27-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 27-Dec-2022, the patient experienced VACCINATION SITE PAIN (she felt a burning sensation). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (red swollen injection site), VACCINATION SITE SWELLING (red swollen injection site) and SENSORY LOSS (reduced (not total numbness) sense of feeling in her entire left arm and hands). At the time of the report, VACCINATION SITE PAIN (she felt a burning sensation) had not resolved and VACCINATION SITE ERYTHEMA (red swollen injection site), VACCINATION SITE SWELLING (red swollen injection site) and SENSORY LOSS (reduced (not total numbness) sense of feeling in her entire left arm and hands) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. The patient had the two original Moderna vaccines and 2 boosters. Patient was so angry and never had any reaction at all then had one yesterday 27-Dec-2022. Patient got 8 pages of what to expect from the vaccine and read the side effects, but nowhere has it told anything about what can do for those side effects. The patient was thinking to put heat or take some aspirin or Aleve. Patient doesn't want to screw it up and go through it again and also stated that the CVS didn't even have the vaccine. Patient was used to hear information on TV, but there is a lack of information, like when to get the next dose.  No treatment medications were reported.
Pain that has moved up to left shoulder; Radiating pain; This case was reported by a consumer via interactive digital media and described the occurrence of shoulder pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shoulder pain and radiating pain. On an unknown date, the outcome of the shoulder pain and radiating pain were unknown.   It was unknown if the reporter considered the shoulder pain and radiating pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 13-AUG-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient experienced the pain after receiving Shingrix that had moved up to left shoulder. Follow-up would not possible, as no contact details were available.
No adverse events,  only notified of mistake.  Pt had no effect adverse or normal from vaccine.
1 of twins were fine following vax; 48 hrs later devel uncontrolable screaming episode which lasted 2 hrs; pt devel purplish discoloration from mid thigh down (site unspecified); next day back to nl;
Stomach is not feeling good; Weakness; Chills; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Stomach is not feeling good), ASTHENIA (Weakness), CHILLS (Chills) and FATIGUE (Tiredness) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032120A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach is not feeling good), ASTHENIA (Weakness), CHILLS (Chills) and FATIGUE (Tiredness). At the time of the report, ABDOMINAL DISCOMFORT (Stomach is not feeling good), ASTHENIA (Weakness), CHILLS (Chills) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitants and treatment were not reported.   Reporter did not allow further contact
recived injection on 7-25-2007 that afternoon began with nausea and vomiting and some dizziness, had no other reasons or new meds that would have caused this reaction, the next day still c/o dizziness but was much better, after the 3rd day was completely better.
Backache, 10 hours after 1st IM exposure dose. Backache within 15 minutes of 2nd dose.
Stomach pain; nausea.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 17 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 08May2021 (Batch/Lot number: unknown) at the age of 16 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: ABDOMINAL PAIN UPPER (non-serious) with onset 12Aug2021, outcome "not recovered", described as "Stomach pain"; NAUSEA (non-serious) with onset 12Aug2021, outcome "not recovered", described as "nausea.". Therapeutic measures were taken as a result of abdominal pain upper, nausea.  Additional information: Patient had administered vaccine Facility at Pharmacy or Drug Store. Patient had not received other vaccine in four weeks. Patient had not received other medications in two weeks. Patient had not covid prior vaccination. Patient had not covid tested post vaccination. Patient had received OTC meds for Ae treatment.  Follow-up attempts are completed. No further information is expected.
Patient reported fatigue starting 11/15/19. Swelling on right upper arm at the site of pneumovax injection started in the AM of 11/16/19. Site was a about 4 inches of redness. The swelling had not worsened in the 24 hours and may have started to decrease at the time of the report
Rash right upper arm. No fever. Rash faded over 14 days. Took prescribed.  Cephalexin 500 mg capsules to prevent cellulitis.
Time of injectio patient felt a very cold stream going down left arm, made questioned/commented on the coldness going down arm while looking at arm to see if fluid was going down arm. Patient asked and commented is that supposed to be cold and patient stated that this injection didnt feel like the prior years shot. Assistant didn't really answer and I was dismissed.  The normal injection site pain was there for more than four days and the arm was not as it was before shot.  8 months later patient still experiencing limited motion, pain, burning feeling in and on the left arm and wrist. Patient going to PT and doing exercises. Patient had no signs of Arthritis before injection.  Took Xray, Dr. says it's Arthritis and to use over the counter Voltaren. Patient did so for short time. Voltaren instructions say not to use on uper body or if taking Blood Pressure medicine. Patient stoped  using Voltaren. Dr. referred to Physical Therapy. Patient has moments of unexpected weakness, pain and limited motion. Patient was a part time caregiver but can no longer lift transfer or do the things I use to do for Severely disabled Grand daughter. The parents of said child use to leave me home to care for her but now one of the parents has to stay just to help me out with caring for child.  I was their only help other than nurse.
Listless, lethargic, high body temperature, fussy, irritable, excessive sleeping, much less responsive, pain in muscles, joints, and stomach bloated and hot, diarrhea.
Body aches; fever; nausea; pain in injection site; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), PYREXIA (fever), NAUSEA (nausea), VACCINATION SITE PAIN (pain in injection site) and CHILLS (chills) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041l20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced MYALGIA (Body aches), PYREXIA (fever), NAUSEA (nausea), VACCINATION SITE PAIN (pain in injection site), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, MYALGIA (Body aches), PYREXIA (fever), NAUSEA (nausea), VACCINATION SITE PAIN (pain in injection site), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.